Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Expectations and clinical meaningfulness of randomized controlled trialsRonald C Petersen, Paul S Aisen, J Scott Andrews, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An updateJames A Hendrix, Brad Finger, Michael W Weiner, et al.
Neurobiology of Aging|March 21, 2017
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issuesCorinna Porteri, Emiliano Albanese, Charles Scerri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Early risk assessment for Alzheimer's diseaseMaria C Carrillo, Andrew Blackwell, Harald Hampel, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerationsRonald C Petersen, Ana Graf, Chris Brady, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Scales as outcome measures for Alzheimer's diseaseRonald Black, Barry Greenberg, J Michael Ryan, et al.
Growth Factors (Chur, Switzerland)|January 30, 2010
Attenuation of the Wnt/beta-catenin/TCF pathway by in vivo interferon-alpha2b (IFN-alpha2b) treatment in preneoplastic rat liversJuan P Parody, Maria L Alvarez, Ariel D Quiroga, et al.
Psychology and Aging|April 6, 2002
Aging effects on memory encoding in the frontal lobesGlenn T Stebbins, Maria C Carrillo, Jennifer Dorfman, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Expectations and clinical meaningfulness of randomized controlled trialsRonald C Petersen, Paul S Aisen, J Scott Andrews, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An updateJames A Hendrix, Brad Finger, Michael W Weiner, et al.
Neurobiology of Aging|March 21, 2017
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issuesCorinna Porteri, Emiliano Albanese, Charles Scerri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Early risk assessment for Alzheimer's diseaseMaria C Carrillo, Andrew Blackwell, Harald Hampel, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerationsRonald C Petersen, Ana Graf, Chris Brady, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Scales as outcome measures for Alzheimer's diseaseRonald Black, Barry Greenberg, J Michael Ryan, et al.
Growth Factors (Chur, Switzerland)|January 30, 2010
Attenuation of the Wnt/beta-catenin/TCF pathway by in vivo interferon-alpha2b (IFN-alpha2b) treatment in preneoplastic rat liversJuan P Parody, Maria L Alvarez, Ariel D Quiroga, et al.
Psychology and Aging|April 6, 2002
Aging effects on memory encoding in the frontal lobesGlenn T Stebbins, Maria C Carrillo, Jennifer Dorfman, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Pageof 25